UL Solutions (ULS) Prices 20M Share Secondary Offering at $49/sh

UL Solutions Inc. (NYSE: ULS) (“UL Solutions”) today announced the pricing of its underwritten public offering (the “offering”) of 20,000,000 shares of its Class A common stock at a public offering price of $49.00 per share. The offering consists entirely of secondary shares to be sold by UL Standards & Engagement (the “selling stockholder”). The underwriters have a 30-day option to purchase up to an additional 3,000,000 shares of Class A common stock from the selling stockholder at the public offering price, less underwriting discounts and commissions. UL Solutions is not offering any shares of its Class A common stock in the proposed offering and will not receive any proceeds from the proposed sale of the shares. The offering is expected to close on September 9, 2024, subject to customary closing conditions.

Goldman Sachs & Co. LLC and J.P. Morgan (in alphabetical order) are acting as lead managing bookrunners with BofA Securities acting as a managing bookrunner. Citigroup, UBS Investment Bank and Jefferies are acting as additional bookrunners for the proposed offering. Baird, Houlihan Lokey, PNC Capital Markets LLC, Raymond James, Stifel, Wells Fargo Securities, William Blair, AmeriVet Securities, Bancroft Capital, Cabrera Capital Markets LLC, Loop Capital Markets and R. Seelaus & Co., LLC are acting as co-managers for the proposed offering.

The offering is being made only by means of a prospectus. When available, copies of the final prospectus relating to the offering may be obtained from: Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, via telephone: (866) 471-2526, via fax: 212-902-9316, or via email: [email protected] and J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at [email protected] and [email protected].

A registration statement on Form S-1 relating to the offering of these securities was declared effective by the U.S. Securities and Exchange Commission on September 5, 2024. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

You May Also Be Interested In

• enVVeno Medical (NVNO) files $100M mixed shelf
• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• Andersen closes secondary offering of 4.9M shares at $44 each